scholarly article | Q13442814 |
P2093 | author name string | Chouaib S | |
Frank I | |||
Chehimi J | |||
Marshall JD | |||
Rifat S | |||
Salvucci O | |||
Kawecki S | |||
Chehimi S | |||
Bacheller D | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5978-5987 | |
P577 | publication date | 1997-06-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | IL-15 enhances immune functions during HIV infection | |
P478 | volume | 158 |
Q30385378 | A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes. |
Q45747794 | Activation, survival and apoptosis of CD45RO+ and CD45RO- T cells of human immunodeficiency virus-infected individuals: effects of interleukin-15 and comparison with interleukin-2. |
Q34150316 | Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity |
Q24671177 | Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo |
Q40042449 | Dose of Retroviral Infection Determines Induction of Antiviral NK Cell Responses |
Q77481938 | Effect of interleukin (IL)-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection |
Q39830948 | HIV integrase and the swan song of the CD4 T cells? |
Q33987553 | High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model |
Q37459228 | Homeostatically Maintained Resting Naive CD4+ T Cells Resist Latent HIV Reactivation. |
Q77723457 | IL-15 in human visceral leishmaniasis caused by Leishmania infantum |
Q42453465 | IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses |
Q40049630 | Immunobiology of the IL-15/IL-15Rα complex as an antitumor and antiviral agent |
Q41052681 | Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production |
Q39592514 | Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction |
Q41056209 | Interleukin 7 increases human immunodeficiency virus type 1 LAI-mediated Fas-induced T-cell death. |
Q36202607 | Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation |
Q33747897 | Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. |
Q42027307 | Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques |
Q28566473 | Interleukin-15 may be responsible for early activation of intestinal intraepithelial lymphocytes after oral infection with Listeria monocytogenes in rats. |
Q38959284 | Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy |
Q33941869 | MRN-100, an Iron-based Compound, Possesses Anti-HIV Activity In Vitro. |
Q37387255 | Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro |
Q83189114 | Natural-killer cell-derived cytolytic molecules in HIV-associated pulmonary tuberculosis-role of exogenous interleukins |
Q41904728 | Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections |
Q52007748 | Studies on the production of IL-15 in HIV-infected/AIDS patients. |
Q33878183 | The interaction of intestinal epithelial cells and intraepithelial lymphocytes in host defense |
Q24599103 | The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use |
Search more.